Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments.
Privia Health Group's 3-Year RORE % for the quarter that ended in Mar. 2026 was 2.33%.
The industry rank for Privia Health Group's 3-Year RORE % or its related term are showing as below:
PRVA's 3-Year RORE % is ranked better than 52.07% of 605
companies
in the Healthcare Providers & Services industry
Industry Median: 0.07
vs PRVA: 2.33
Privia Health Group (NAS:PRVA) 3-Year RORE % Explanation
Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.
There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 3-year period is chosen.
Be Aware
Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.
Privia Health Group 3-Year RORE % Related Terms
Privia Health Group 3-Year RORE % Historical Data
* Premium members only.
The historical data trend for Privia Health Group's 3-Year RORE % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, Privia Health Group's 3-Year RORE %, along with its competitors' market caps and 3-Year RORE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Privia Health Group 3-Year RORE % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Privia Health Group's 3-Year RORE % distribution charts can be found below:
* The bar in red indicates where Privia Health Group's 3-Year RORE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of 3-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Mar. 2026 and 3-year before.
Privia Health Group (PRVA) has a 3-Year RORE % of 2.33 as of Mar. 2026. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on Privia Health Group and its competitors. According to the industry distribution chart, Privia Health Group ranks #290 out of 605 companies in the Healthcare Providers & Services industry, placing it in the top 47.9%.
Is Privia Health Group's 3-Year RORE % too high?
Privia Health Group's current 3-Year RORE % is 2.33. The Healthcare Providers & Services industry median 3-Year RORE % is 0.07. Privia Health Group's value of 2.33 is 3228.6% above this industry median. Based on the distribution chart, Privia Health Group ranks #290 out of 605 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Privia Health Group has a GF Score™ of 85/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Privia Health Group's 3-Year RORE % compare to HTFL and WAY?
According to the Healthcare Providers & Services industry distribution chart, Privia Health Group ranks #290 out of 605 companies for 3-Year RORE %. This puts Privia Health Group in the upper half of its industry. The industry median 3-Year RORE % is 0.07. Privia Health Group's value of 2.33 is 3228.6% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year RORE % for a Healthcare Providers & Services company?
The median 3-Year RORE % among Healthcare Providers & Services companies is 0.07, based on 605 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year RORE % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year RORE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Privia Health Group's current 3-Year RORE % of 2.33 is 3228.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year RORE % mean?
A high 3-Year RORE % can signal that a stock is expensive relative to its fundamentals. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on Privia Health Group and its competitors. For the Healthcare Providers & Services industry, the median 3-Year RORE % is 0.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Privia Health Group's current 3-Year RORE % is 2.33. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Privia Health Group stock overvalued right now?
Based on GuruFocus' analysis, Privia Health Group (PRVA) is currently considered Fairly Valued. The stock's GF Value™ is $27.41, compared to a current price of $27.36 — trading 0.2% below its estimated fair value. The current 3-Year RORE % is 2.33 and 3228.6% above the Healthcare Providers & Services industry median of 0.07. Privia Health Group's overall GF Score™ is 85/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year RORE % calculated?
3-Year RORE % is calculated from a company's financial statements. For Privia Health Group (PRVA), the current 3-Year RORE % is 2.33 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Privia Health Group (PRVA) Overvalued in 2026?
Based on GuruFocus' analysis, Privia Health Group stock appears to be undervalued.
The current stock price of $27.36 is trading 0.2% below its estimated GF Value™ of $27.41.
GuruFocus considers Privia Health Group to be Fairly Valued.
Key valuation signals for PRVA:
3-Year RORE %: 2.33
GF Value™: $27.41 vs. price of $27.36 (0.2% below fair value)
Industry Position: 3228.6% above the Healthcare Providers & Services median (#290 of 605)
No single metric tells the full story. See the PRVA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Privia Health Group Inc is one of the physician enablement companies in the United States with a presence in around 24 states and the District of Columbia. The group builds scaled provider networks with primary-care centric medical groups, risk-bearing entities, a physician-led governance structure, and the Privia Platform comprising an extensive suite of technology and service solutions. It collaborates with medical groups, health plans, and health systems to optimize approximately 1,300+ physician practices, improve the patient experience for over 5.8+ million patients, and reward around 5,300+ physicians and practitioners for delivering high-value care.
85GF Score
Get the complete analysis for PRVA
3-Year RORE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PRVA has been successfully added to your 
